methylformamide has been researched along with B16 Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amedeo, C; Biroccio, A; Bucci, B; Del Bufalo, D; Falcioni, R; Leonetti, C; Zupi, G | 1 |
| Candiloro, A; Cucco, C; D'Agnano, I; Marangolo, M; Zupi, G | 1 |
2 other study(ies) available for methylformamide and B16 Melanoma
| Article | Year |
|---|---|
N-methylformamide induces changes on adhesive properties and lung-colonizing potential of M14 melanoma cells.
Topics: Animals; Cell Adhesion; Cell Adhesion Molecules; Extracellular Matrix Proteins; Fibrinogen; Formamides; Humans; Integrins; Lung; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Importance of cell cycle perturbations on the effectiveness of N-methylformamide and anti-neoplastic drugs in combination.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Cycle; Cell Survival; Cisplatin; Colonic Neoplasms; Doxorubicin; Flow Cytometry; Formamides; Humans; Melanoma, Experimental; Tumor Cells, Cultured | 1991 |